Where Global Innovation
and Capital Meet


SenseTime scores $851m in initial public offering

The producer of image recognition technology stemmed from Chinese University of Hong Kong’s Media Lab has gone public in Hong Kong as the Chinese government introduces new regulations governing foreign IPOs.

Dec 31, 2021

Exits: November 26, 2021

A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.

Nov 26, 2021

Entrada Therapeutics enters Nasdaq

The Ohio State spinout has gone public in an upsized IPO sized at approximately $182m.

Nov 11, 2021

Pyxis progresses to stock market

Having priced its shares at the top of its range, UChicago spinout Pyxis Oncology suffered a drop on the first day of trading.

Oct 11, 2021

Exscientia expands IPO to over $350m

The cancer drug developer has closed its initial public offering after underwriters exercised the greenshoe option.

Oct 7, 2021

Pyxis picks price range

UChicago spinout Pyxis Oncology is aiming to raise more than $153m in its initial public offering, having set a price range of $14 to $16.

Oct 5, 2021

Exscientia establishes Nasdaq listing

The Dundee spinout has raised more than $304m in its IPO in the US, with another $160m secured through a concurrent private placement.

Oct 4, 2021

Other News

Li-S Energy celebrates market debut

Based on research at Deakin University, Li-S Energy has gone public on the Australian Stock Exchange after raising $25m in its initial public offering.

Sep 30, 2021

Lucid Diagnostics lines up IPO

Case Western Reserve University-linked Lucid Diagnostics is seeking an initial public offering that would net it up to $57.5m.

Sep 28, 2021

Oxford Nanopore sets IPO plans in motion

Oracle has signed up to be a cornerstone investor for Oxford Nanopore’s initial public offering, putting up half of the $410m target.

Sep 21, 2021

Context Therapeutics frames IPO plans

Based on research at Drexel University, Context Therapeutics is seeking to raise up to $21m in an initial public offering on Nasdaq.

Sep 15, 2021

Exscientia explores Nasdaq IPO

Dundee spinout Exscientia is continuing a busy fundraising year with a filing for an IPO in the US and a $35m concurrent private placement.

Sep 13, 2021

Icosavax lands on $182m IPO

UW's vaccine development company has listed on Nasdaq, with its shares rising on the first day of trading.

Aug 2, 2021

Editor's Picks

SenseTime sets $767m target for IPO

Corporate-backed artificial intelligence technology developer SenseTime has set terms for an offering which could illustrate where China's troubled public markets space currently lies.

Dec 6, 2021

Selina seals reverse merger deal

The Access Industries and Grupo Wiese-backed workspace and short-term accommodation service is merging with BOA Acquisition Corp in a reverse takeover at a valuation of about $1.2bn.

Dec 3, 2021

Braze breaches public markets in $520m IPO

Citi Ventures-backed Braze priced the offering above its range and it valued the customer engagement software producer at almost $5.9bn.

Nov 18, 2021

Paytm puts together $2.5bn IPO

The Alibaba, Ant Group, Berkshire Hathaway, Intel and SoftBank-backed e-commerce payment app operator is set to list on the NSE and BSE next week at a potential valuation of up to $18.7bn.

Nov 12, 2021
© 2021 Mawsonia Ltd. All rights reserved.
test reg